View in EDS HTML Full Text PDF Full Text

Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study.

Saved in:
Bibliographic Details
Title: Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study.
Authors: Kirste S; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany., Kroeze SGC; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland., Henkenberens C; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany., Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Vogel MME; Department of Radiation Oncology, Technical University Munich, Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum Munich, Oberschleissheim, Germany., Becker J; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany., Zamboglou C; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany., Burger I; Department of Nuclear Medicine, University Hospital Zürich, University of Zurich, Zurich, Switzerland., Derlin T; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany., Bartenstein P; Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany., Ruf J; Department of Nuclear Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., la Fougère C; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany., Eiber M; Department of Nuclear Medicine, Technical University Munich, Munich, Germany., Christiansen H; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany., Combs SE; Department of Radiation Oncology, Technical University Munich, Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum Munich, Oberschleissheim, Germany., Müller AC; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany., Belka C; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Guckenberger M; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland., Grosu AL; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
Source: Frontiers in oncology [Front Oncol] 2021 May 10; Vol. 11, pp. 640467. Date of Electronic Publication: 2021 May 10 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34041020
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combining <superscript>68</superscript>Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kirste+S%22">Kirste S</searchLink>; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kroeze+SGC%22">Kroeze SGC</searchLink>; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Henkenberens+C%22">Henkenberens C</searchLink>; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Schmidt-Hegemann+NS%22">Schmidt-Hegemann NS</searchLink>; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Vogel+MME%22">Vogel MME</searchLink>; Department of Radiation Oncology, Technical University Munich, Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum Munich, Oberschleissheim, Germany.<br /><searchLink fieldCode="AU" term="%22Becker+J%22">Becker J</searchLink>; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Zamboglou+C%22">Zamboglou C</searchLink>; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Burger+I%22">Burger I</searchLink>; Department of Nuclear Medicine, University Hospital Zürich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Derlin+T%22">Derlin T</searchLink>; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Bartenstein+P%22">Bartenstein P</searchLink>; Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Ruf+J%22">Ruf J</searchLink>; Department of Nuclear Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22la+Fougère+C%22">la Fougère C</searchLink>; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Eiber+M%22">Eiber M</searchLink>; Department of Nuclear Medicine, Technical University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Christiansen+H%22">Christiansen H</searchLink>; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Combs+SE%22">Combs SE</searchLink>; Department of Radiation Oncology, Technical University Munich, Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum Munich, Oberschleissheim, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+AC%22">Müller AC</searchLink>; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Belka+C%22">Belka C</searchLink>; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Guckenberger+M%22">Guckenberger M</searchLink>; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Grosu+AL%22">Grosu AL</searchLink>; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2021 May 10; Vol. 11, pp. 640467. <i>Date of Electronic Publication: </i>2021 May 10 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34041020
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2021.640467
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 640467
    Titles:
      – TitleFull: Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kirste S
      – PersonEntity:
          Name:
            NameFull: Kroeze SGC
      – PersonEntity:
          Name:
            NameFull: Henkenberens C
      – PersonEntity:
          Name:
            NameFull: Schmidt-Hegemann NS
      – PersonEntity:
          Name:
            NameFull: Vogel MME
      – PersonEntity:
          Name:
            NameFull: Becker J
      – PersonEntity:
          Name:
            NameFull: Zamboglou C
      – PersonEntity:
          Name:
            NameFull: Burger I
      – PersonEntity:
          Name:
            NameFull: Derlin T
      – PersonEntity:
          Name:
            NameFull: Bartenstein P
      – PersonEntity:
          Name:
            NameFull: Ruf J
      – PersonEntity:
          Name:
            NameFull: la Fougère C
      – PersonEntity:
          Name:
            NameFull: Eiber M
      – PersonEntity:
          Name:
            NameFull: Christiansen H
      – PersonEntity:
          Name:
            NameFull: Combs SE
      – PersonEntity:
          Name:
            NameFull: Müller AC
      – PersonEntity:
          Name:
            NameFull: Belka C
      – PersonEntity:
          Name:
            NameFull: Guckenberger M
      – PersonEntity:
          Name:
            NameFull: Grosu AL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 05
              Text: 2021 May 10
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1